Company Quick10K Filing
Mateon Therapeutics
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-29
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-10
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
S-1 2018-06-13 Public Filing
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-08
10-K 2016-12-31 Filed 2017-03-30
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-03-25
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-20
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-15
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-11
10-K 2011-12-31 Filed 2012-03-28
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-16
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-16
8-K 2020-08-19 Other Events, Exhibits
8-K 2020-08-18 Other Events, Exhibits
8-K 2020-08-10 Shareholder Vote
8-K 2020-08-07 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-07-24 Enter Agreement, Exhibits
8-K 2020-07-23 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2020-06-12
8-K 2020-06-10
8-K 2020-06-08
8-K 2020-05-11
8-K 2020-05-10
8-K 2020-05-05
8-K 2020-05-04
8-K 2020-04-24
8-K 2020-04-21
8-K 2020-04-20
8-K 2020-04-16
8-K 2020-04-08
8-K 2020-04-06
8-K 2020-04-02
8-K 2020-03-25
8-K 2020-03-18
8-K 2020-03-02
8-K 2020-01-15
8-K 2020-01-06
8-K 2019-12-31
8-K 2019-12-27
8-K 2019-12-20
8-K 2019-12-11
8-K 2019-12-06
8-K 2019-11-27
8-K 2019-11-23
8-K 2019-11-23
8-K 2019-11-18
8-K 2019-11-01
8-K 2019-10-29
8-K 2019-10-23
8-K 2019-10-07
8-K 2019-09-23
8-K 2019-09-05
8-K 2019-09-03
8-K 2019-08-23
8-K 2019-08-17
8-K 2019-08-06
8-K 2019-07-30
8-K 2019-07-29
8-K 2019-07-22
8-K 2019-07-16
8-K 2019-07-01
8-K 2019-06-14
8-K 2019-06-10
8-K 2019-06-04
8-K 2019-05-30
8-K 2019-04-30
8-K 2019-04-22
8-K 2019-04-17
8-K 2019-04-10
8-K 2018-06-18
8-K 2018-04-12

Mateon Therapeutics Financials

OXGN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Santa Fe Gold (SFEG) 61,079 6.6 729% 1,228 15,246 0 0 8,947 9,931 65,322
Emarine Global (EMRN) 60,630 48% 1.5 4% 3,475,740 7,588,357 3,595,221 1,725,943 123,731 400,532 611,829
iWeb (IWBB) 60,297 -109.5 -40% 1,355 222 0 0 -548 -546 59,715
Lightwave Logic (LWLG) 59,578 -9.9 -99% 6,603 1,842 0 0 -6,508 -5,828 57,410
China Health Industries (CHHE) 58,986 75% 4.3 8% 44,808 8,362 9,187 6,914 3,431 5,600 24,004
Research Solutions (RSSS) 58,660 30% -66.0 -8% 10,500 7,483 29,437 8,712 -864 -804 53,072
Mateon Therapeutics (OXGN) 58,429 -21.4 -37% 7,529 2,728 0 0 -2,813 -2,725 58,413
Aerogrow (AERO) 58,358 33% -28.0 -12% 20,938 10,670 30,944 10,128 -2,487 -2,210 61,797
Intelgenx Technologies (IGXT) 57,987 0% -7.1 -61% 13,067 10,428 674 0 -7,999 -7,701 55,050
Invesco DB Energy Fund (DBE) 57,876 5.8 17% 57,446 1,398 0 0 9,989 9,998 57,876
Ambase (ABCP) 57,848 -13.3 -27% 14,738 633 0 0 -4,032 -4,061 53,899
Insurance Acquisition (INSUU)
Propel Media (PROM) 57,502 68% 2.6 24% 40,227 67,463 89,698 61,206 9,581 40,275 102,755
Protokinetix (PKTX) 57,309 -32.7 -354% 492 5 0 0 -1,744 -1,744 57,019
Lexaria Bioscience (LXRP) 70,079 188% -16.1 -124% 3,457 132 97 183 -4,270 -4,216 68,083
NaturalShrimp (SHMP) 56,698 -7.8 -253% 2,967 5,223 0 0 -7,504 -7,277 56,414
Greenbox Pos (GRBX) 56,573 83% -10.4 -738% 750 919 588 489 -5,535 -5,452 56,573
Highlands Bankshares (HBKA) 55,852 5.1 0% 575,274 513,906 0 0 2,477 6,475 33,031
CTD Holdings (CTDH) 55,713 92% -10.4 -84% 5,862 2,379 780 717 -4,898 -4,898 50,719
IEH Corporation (IEHC) 55,524 30% 6.8 14% 29,026 4,472 27,884 8,433 4,193 7,167 48,961

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash8,46012,6449,9728,1466,9026,3034,9464,5627,7328,7777,00524,73536,27132,88730,03135,73533,09330,25127,28510,2767,9395,16712,0008,3005,0041,9081,1152331,9661,0586292008416
Accounts Receivable
Inventory
PP&E836836643643644644370371365365304322830279324236268251914268864268268
Assets9,46013,37511,0568,9887,7366,8675,4475,1828,3059,2217,29425,24636,84733,25330,42336,55533,63930,73627,45324,24120,42817,26114,11410,1756,5292,9751,1724372,0991,1497993917,6607,529
Accounts Payable4404732611385355094164454307334764328493653351891783172874755015323103124013127881,1641,2217729159011,1841,365
Long-Term Debt
Liabilities2,2382,9782,2591,4751,6181,2519018338911,5151,2511,3951,9481,6741,4191,0291,1661,6982,1032,0241,6171,4851,6141,3931,4251,2111,6491,5241,5611,0911,1611,1742,0432,728
Stockholders' Equity7,22210,3978,7977,5136,1185,6164,5464,3497,4147,7066,04323,85134,89931,57929,00435,52632,47329,03825,35022,21718,81115,77612,5008,7825,1041,764-477-1,08753858-362-7835,6164,800
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue11400095000
Cost of Revenue
Gross Profit
R&D1,4991,0981,0116541,0801,0157747466031,1651,1221,3872,3932,2401,6101,6691,9812,4572,9791,9802,3742,0752,3352,8483,0192,8321,77222534295135364344
SG&A1,4011,3091,2801,3321,2221,2209391,1351,0521,5779751,2411,7531,2131,0351,1081,3471,1429991,3721,2961,1871,1401,122877708664570556585499797587
Tax0
Net Income-2,932-3,513-2,345-1,891-644-2,247-1,675-1,880-1,287-2,646-2,097-2,630-3,913-3,450-2,638-2,772-3,324-3,592-3,966-3,325-3,641-3,236-3,453-3,958-3,884-3,536-2,434-7942,100-675-633-1,189-991
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-2,439-2,807-2,785-1,984-2,169-1,397-1,894-1,448-1,529-2,130-2,624-3,303-2,846-3,503-2,615-2,843-2,966-4,399-3,545-3,061-4,233-3,703-3,340-3,096-793-882-625-908-429-464-443
Cash Investing-1111-12,6101,2082892,6016,2092,303000
Cash Financing6,6231359597401,570481,5104,6182,57439320,35414,83919,207-120-1375